Marco Battaglini

8PUBLICATIONS
34CO-AUTHORS
Neurology and neuromuscular diseasesBiomedical instrumentationAutoimmunityGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 09, 2026
The predictive value of serum neurofilament light chain levels beyond MRI measures for clinical and radiological disease progression in the earliest stages of multiple sclerosis.

|Aug 02, 2023
BIANCA-MS: An optimized tool for automated multiple sclerosis lesion segmentation.

Giordano Gentile, Mark Jenkinson, Ludovica Griffanti

|Feb 01, 2023
Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a.

H Vrenken, M Battaglini, M L de Vos

|Sep 28, 2022
Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets.

Rosa Cortese, Marco Battaglini, Maria Pia Sormani

|Mar 11, 2022
Evolution from a first clinical demyelinating event to multiple sclerosis in the REFLEX trial: Regional susceptibility in the conversion to multiple sclerosis at disease onset and its amenability to subcutaneous interferon beta-1a.

Marco Battaglini, Hugo Vrenken, Riccardo Tappa Brocci

|Jan 14, 2018
Deep gray matter volume loss drives disability worsening in multiple sclerosis.

Arman Eshaghi, Ferran Prados, Wallace J Brownlee

Pageof 2

Frequent Collaborators

5 joint publications

Nicola De Stefano

4 joint publications

Giordano Gentile

3 joint publications

Hugo Vrenken

3 joint publications

Frederik Barkhof